1.42
price up icon2.16%   0.03
after-market Handel nachbörslich: 1.42
loading
Schlusskurs vom Vortag:
$1.39
Offen:
$1.36
24-Stunden-Volumen:
51,316
Relative Volume:
0.05
Marktkapitalisierung:
$1.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.29M
KGV:
-0.2731
EPS:
-5.2
Netto-Cashflow:
$-9.42M
1W Leistung:
-2.74%
1M Leistung:
+5.19%
6M Leistung:
-41.32%
1J Leistung:
-63.02%
1-Tages-Spanne:
Value
$1.35
$1.4654
1-Wochen-Bereich:
Value
$1.35
$1.525
52-Wochen-Spanne:
Value
$1.20
$6.18

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile

Name
Firmenname
Scinai Immunotherapeutics Ltd Adr
Name
Telefon
972-8-9302529
Name
Adresse
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM
Name
Mitarbeiter
31
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
SCNI's Discussions on Twitter

Vergleichen Sie SCNI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SCNI
Scinai Immunotherapeutics Ltd Adr
1.42 4.81M 0 -9.29M -9.42M -5.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.63 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.00 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.69 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.18 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.03 34.68B 4.56B -176.77M 225.30M -1.7177

Scinai Immunotherapeutics Ltd Adr Aktie (SCNI) Neueste Nachrichten

pulisher
Oct 06, 2025

Scinai receives $246,000 grant to expand biotech manufacturing By Investing.com - Investing.com South Africa

Oct 06, 2025
pulisher
Oct 06, 2025

Scinai receives $246,000 grant to expand biotech manufacturing - Investing.com

Oct 06, 2025
pulisher
Sep 03, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Reports First-Half 2025 Results, Strengthened Cash Position - Barchart.com

Sep 03, 2025
pulisher
Sep 02, 2025

Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet - Barchart.com

Sep 02, 2025
pulisher
Aug 26, 2025

Scinai Immunotherapeutics (NASDAQ:SCNI) Trading Down 3.8% – Here’s What Happened - Defense World

Aug 26, 2025
pulisher
Jul 29, 2025

Scinai Immunotherapeutics Ltd ADR (SCNI) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Publishes Peer-Reviewed Data Supporting PC111 as Potential Disease Modifier - Barchart.com

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Immunotherapeutics stock soars on promising skin disease drug data By Investing.com - Investing.com South Africa

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Immunotherapeutics stock soars on promising skin disease drug data - Investing.com Australia

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai’s PC111 antibody shows promise for pemphigus treatment By Investing.com - Investing.com Canada

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai’s PC111 antibody shows promise for pemphigus treatment - Investing.com India

Jul 29, 2025
pulisher
Jul 29, 2025

ICICI Bank Ltd. ADR (IBN) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN - Benzinga

Jul 29, 2025
pulisher
Jun 19, 2025

Augusta Gold (TSE:G) Shares Pass Below Two Hundred Day Moving Average – Time to Sell? - Defense World

Jun 19, 2025
pulisher
Jun 04, 2025

Scinai Immunotherapeutics Faces Financial Challenges, Seeks Growth - TipRanks

Jun 04, 2025
pulisher
Jun 02, 2025

Scinai Immunotherapeutics Reports Strong CDMO Growth - TipRanks

Jun 02, 2025
pulisher
May 09, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - Barchart.com

May 09, 2025
pulisher
May 08, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Reports $4.8M Net Gain in 2024, Driven by Loan-to-Equity Conversion - Barchart.com

May 08, 2025
pulisher
May 01, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) to Host Webinar on PC111 Antibody for Rare Skin Disorders - Barchart.com

May 01, 2025
pulisher
Apr 01, 2025

Military Breakthrough: BrainChip and Raytheon Land $1.8M Air Force Deal for Next-Gen Radar - Stock Titan

Apr 01, 2025
pulisher
Mar 27, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Enters Option Agreement to Acquire Italian Biotech Pincell - The Globe and Mail

Mar 27, 2025
pulisher
Sep 26, 2024

Bayerische Motoren Werke ADR (OP: BMWYY - FinancialContent

Sep 26, 2024
pulisher
Jun 07, 2024

Scinai regains Nasdaq compliance, eyes EIB loan conversion - Investing.com

Jun 07, 2024
pulisher
May 06, 2024

Scinai Immunotherapeutics enacts reverse split to meet Nasdaq rules - Investing.com

May 06, 2024
pulisher
Oct 30, 2023

Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Participation at BIO-Europe Munich 2023 - Barchart.com

Oct 30, 2023

Finanzdaten der Scinai Immunotherapeutics Ltd Adr-Aktie (SCNI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$36.85
price up icon 0.03%
$89.31
price up icon 1.42%
$29.87
price down icon 0.17%
$104.75
price down icon 1.39%
$160.11
price down icon 0.18%
biotechnology ONC
$310.03
price down icon 1.12%
Kapitalisierung:     |  Volumen (24h):